Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.657 Good afternoon. My name is Sherry, and I will be your conference call operator today. 00:00:04.657 -- 00:00:08.022 At this time, all participants are in a listen-only mode. 00:00:08.022 -- 00:00:12.267 After the speaker's formal remarks, there will be a question and answer session. 00:00:12.267 -- 00:00:16.733 If you would like to ask a question during that time, simply press the star key, then 00:00:16.733 -- 00:00:21.339 the number one on your telephone keypad. If you would like to withdraw your questions, 00:00:21.339 -- 00:00:26.586 please press star two. If you should require operator assistance during the conference, 00:00:26.586 -- 00:00:31.128 please press star zero. As a reminder, this call is being recorded. 00:00:31.128 -- 00:00:36.074 I would now like to turn the conference over to Marianne Ohannesson, Senior Director 00:00:36.074 -- 00:00:39.017 of Investor Relations for PUMA Biotechnology. 00:00:39.017 -- 00:00:41.840 Thank you. You may begin your conference. 00:00:41.840 -- 00:00:46.426 Thank you, Sherry. Good afternoon and welcome to PUMA's conference call to discuss our 00:00:46.426 -- 00:00:49.830 earnings results for the first quarter of 2025. 00:00:49.830 -- 00:00:54.775 Joining me on the call today are Alan Auerbach, Chief Executive Officer, President, and 00:00:54.775 -- 00:00:57.406 Chairman of the Board of PUMA Biotechnology, 00:00:57.406 -- 00:01:02.530 Maximo Noguez, Chief Financial Officer, Jeff Ludwig, Chief Commercial 00:01:02.530 -- 00:01:07.875 Officer, Heather Blaber, Vice President of Marketing, and Jeff Storms, Vice President 00:01:07.875 -- 00:01:09.577 of Sales. 00:01:09.577 -- 00:01:13.800 After the close today, PUMA issued a news release detailing earnings results for first 00:01:13.800 -- 00:0...